Fig. 7From: Exploring the novel duo of Reticulocalbin, and Sideroflexin as future biomarker candidates for Exacerbated Chronic Obstructive Pulmonary DiseaseDiagram showing the implication of differential expression of the proteins-RCN-1, SFXN-4 and LIPα-3 in the pathophysiology of exacerbation COPD. Recent literature review and functional annotation of this proteins taken together with their lung specific expression projects them as potential biomarkers for exacerbation COPDBack to article page